We serve Chemical Name:1-benzoylpiperidin-3-one CAS:67452-85-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-benzoylpiperidin-3-one
CAS.NO:67452-85-1
Synonyms:N-Benzoyl-3-piperidinone;1-BENZOYL-PIPERIDIN-3-ONE;1-Benzoylazan-3-on;1-Benzoyl-3-piperidon;3-Piperidinone,1-benzoyl;AB3058
Molecular Formula:C12H13NO2
Molecular Weight:203.23700
HS Code:2933399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:37.38000
Exact Mass:203.09500
LogP:1.42960
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like N-Benzoyl-3-piperidinone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,AB3058 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,AB3058 Use and application,AB3058 technical grade,usp/ep/jp grade.
Related News: The memo denies the company made false statements to the FDA. In their complaint, employees said they were broadly concerned that quality control documents the FDA requires companies to maintain had been rewritten or fabricated. The employees did not specify whether these materials had been shown to the FDA. 1-benzoylpiperidin-3-one manufacturer From the perspective of product structure, the varieties of these enterprises are mainly concentrated in vitamins, antipyretics and analgesics, antibiotics and corticosteroids (ie bulk drug substances). 1-benzoylpiperidin-3-one supplier The Environmental Working Group, a nonprofit advocacy organization, applauded the bill’s introduction. 1-benzoylpiperidin-3-one vendor The memo denies the company made false statements to the FDA. In their complaint, employees said they were broadly concerned that quality control documents the FDA requires companies to maintain had been rewritten or fabricated. The employees did not specify whether these materials had been shown to the FDA. 1-benzoylpiperidin-3-one factory The memo denies the company made false statements to the FDA. In their complaint, employees said they were broadly concerned that quality control documents the FDA requires companies to maintain had been rewritten or fabricated. The employees did not specify whether these materials had been shown to the FDA.
